Summary: The Deepbridge Life Sciences SEIS is a discretionary portfolio service that will invest into a small portfolio of up to 10 underlying companies, focusing on start-up or early-stage life science companies.
Strategy: Well defined investment process to invest directly in new companies in selected technology areas.
Concentration: Portfolio may be up to nine investments, although smaller investors may get greater concentration.
Team: The Deepbridge team is very experienced in the relevant areas, and its Committees have very strong outside members.
Newer product area: Although Deepbridge has been investing in EIS since 2013, SEIS is a relatively new area.